Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Journal of Education, Health and Sport

Research of changes in the level of endothelin-1 in experimental diabetic retinopathy. comparison of methods of correction
  • Home
  • /
  • Research of changes in the level of endothelin-1 in experimental diabetic retinopathy. comparison of methods of correction
  1. Home /
  2. Archives /
  3. Vol. 11 No. 10 (2021) /
  4. Research Articles

Research of changes in the level of endothelin-1 in experimental diabetic retinopathy. comparison of methods of correction

Authors

  • Y. Sirman Ukrainian Research Institute of Transport Medicine of the Ministry of Health of Ukraine
  • N. Preis Ukrainian Research Institute of Transport Medicine of the Ministry of Health of Ukraine
  • I. Savytskyi Ukrainian Research Institute of Transport Medicine of the Ministry of Health of Ukraine

DOI:

https://doi.org/10.12775/JEHS.2021.11.10.038

Keywords

experimental diabetic retinopathy, endothelial dysfunction, endothelin-1, vasoconstriction, correction

Abstract

Diabetic retinopathy (DR) according to the WHO is the main cause of decreased vision and blindness due to diabetes.

The aim of the study: to compare the effectiveness of correction of vasoconstriction in experimental diabetic retinopathy under the influence of different methods of correction.

Our results indicate a violation of the functional state of blood vessels on the 30th day of experimental diabetic retinopathy with subsequent progression of pathological changes on the 60th and 180th day of the study, as evidenced by a significant increase in endothelin-1 in the 2nd group (p <0.001), most pronounced in the 3rd stage.In the analysis of data of group №3 it was found that the correction of pathological conditions with hypoglycemic agents has a positive effect, but does not allow to significantly correct pathologically increased levels of endothelin-1, which indicates the need for additional correction tools other than hyperglycemia.The results of group 4 indicate that the involvement of a donor of nitric oxide and aflibercept in the correction of diabetic retinopathy corrects the level of the studied marker, the most pronounced effect is observed on the 180th day of the experiment, but normative values can not be achieved. It was found that in the 5th group, in which the correction of the simulated pathological condition was performed by reducing hyperglycemia, the introduction of aflibercept and bromfenac gives positive results, but less pronounced than in the 4th group, where L-arginine solution was added to the complex correction. .It was found that rats of group 6, which simulated diabetic retinopathy with subsequent correction of hyperglycemia, administration of aflibercept, L-carnitine and bromfenac have a pronounced effectiveness of the proposed method of correction compared to previous methods, the level of vasoconstriction stage and continues to recover in the following stages of the experiment, but does not reach the normative values. The obtained data suggest that the method of correction selected in group 7, which includes reduction of hyperglycemia, administration of aflibercept, solution of L-arginine and citicoline is most effective for normalizing vascular tone and structural and functional state of the endothelium.

References

Vorob'eva I. V., Repkina M. YU. Prakticheskie rekomendacii o nablyudenii bol'nyh s diabeticheskoj retinopatiej // RMZH. Endokrinologiya. —2009. — T. 17, № 24. — S. 1591-1595.

Astahov YU. S., Zaleskaya A. G., Karpova I. A. i dr. Faktory, vliyayushchie na progressirovanie diabeticheskoj retinopatii u bol'nyh saharnym diabetom 2 tipa posle perevoda na insulinoterapiyu // Klinicheskaya oftal'mologiya. — 2005. — T. 6, № 3. — S. 110-114.

Abbate M, Cravedi P, Iliev I, et al. Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives // Curr Diabetes Rev. — 2011. — Vol. 7. — P. 190-200.

Vorob'eva I.V., Gigineishvili D.N. Rol' disfunkcii endoteliya v patogeneze diabeticheskoj retinopatii u bol'nyh saharnym diabetom 2 tipa. Obzor. Oftal'mologiya. 2012;9(3):9-13.

American Diabetes Association: Standarts of medical care in diabetes-2011 // Diabetes care. — 2011. — Vol. 34, Suppl. I: S4–88.

SHestakova M. V., SHamhalova M. SH. Sovremennyj podhod k profilaktike i lecheniyu diabeticheskoj retinopatii: rezul'taty issledovaniya DIRECT, 2009. Spravochnik poliklinicheskogo vracha. — 2009. — № 1. — S. 3-39.

Delano FA, Chen AY, Wu KI, et al. The autodigestion hypothesis and receptor cleavage in diabetes and hypertension // Drug Discov Today Dis Models. — 2011. — Vol. 8. — P. 37-46.

Wright AD; Dodson PM. Diabetic Retinopathy and Blockade of the Renin Angiotensin System: New Data from the DIRECT Study Programme // Eye. 2010. — Vol. 24. — P. 1-6.

Porta M, Maldari P, Mazzaglia F. New approaches to the treatment of diabetic retinopathy // Diabetes Obes Metab. — 2011. — Vol. 13. — P. 784-790.

Gavrilova N.A., Tishchenko O.E. Vliyanie sulodeksida na funkcional'noe sostoyanie endoteliya u bol'nyh saharnym diabetom i diabeticheskoj retinopatiej // Saharnyj diabet. 2011. № 2. S. 66–68.

Astahov YU.S., SHadrichev F.E., Lisochkina A.B. Diabeticheskaya retinopatiya // Oftal'mologiya – 2006. Klinicheskie rekomendacii / pod red. L.K. Moshetovoj, A.P. Nesterova, E.A. Egorova. M.: GEOTAR-Media, 2006. S. 139–163.

Kasatkina S. G., Kasatkin S. N. Znachenie disfunkcii endoteliya u bol'nyh saharnym diabetom 2-go tipa // Fundamental'nye issledovaniya. — 2011. — № 7 — S. 248-252.

Neroev V. V., Sarygina O. I., Levkina O. A. Rol' sosudistogo endotelial'nogo faktora rosta v patogeneze diabeticheskoj retinopatii // Vestnik oftal'mologii. — 2009. — № 2. — S. 58-60.

Koledincev M.N., Verzin R.A. Rol' korrekcii sostoyaniya endoteliya i bazal'noj membrany sosudistoj stenki pri diabeticheskoj retinopatii// Effektivnaya farmakoterapiya. Endokrinologiya.- 43/2015.-№5.

Penіshkevich YA.І., Kuchuk O.P., Kuz'o O.O., Klіnіchna anatomіya ta operativna hіrurgіya – T. 15, № 2 – 2016.S. 114-116.

Titov V.N. Anatomicheskie i funkcional'nye osnovy endotelij-zavisimoj vazodilatacii, oksid azota i endotelin / V.N. Titov // Ros. kardiolog. zh. – 2008. – № 1. – S. 71-85.

Xu F.P. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes / F.P. Xu, M.S. Chen, Y.Z. Wang // Circulation. – 2004. – Vol. 110. – P. 1269-1275.

Minushkina L.O. Est' li perspektivy u antagonistov receptorov endotelina? / L.O. Minushkina, D.A. Zatejshchikov // Farmateka. – 2003. –№ 6. – S. 51-58.

Pataraya S.A. Biohimiya i fiziologiya semejstva endotelinov / S.A. Pataraya, D.V. Preobrazhenskij, B.A. Sidorenko // Kardiolog. – 2000. – № 6. – S. 78-85.

Guidry C. Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts / C. Guidry, M. Hook // J. Cell. Biol. – 1991. – Vol. 115. – P. 873-880.

XuF.P. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes / F.P. Xu, M.S. Chen, Y.Z. Wang // Circulation. – 2004. – Vol. 110. – P. 1269-1275.

Pasechnikova N. V. Zashchitnoe dejstvie kvercetina i lipoata na funkcional'nye gruppy belkov setchatki pri modelirovanii diabeta / N.V. Pasechnikova, O.A. Moroz // Oftal'mologіchnij zhurnal. – 2015. – № 3. – S. 76-81

Eksperimental'naya model' saharnogo diabeta 2-go tipa u krys, vyzvannaya dietoj s vysokim soderzhaniem zhirov i streptozotocinom v nizkoj doze / O.A. Kajdash, V.V. Ivanov, A.I. Vengerovskij, E.E. Bujko, I.A. SHCHepetkin // Byulleten' sibirskoj mediciny. – 2020. – №19(2). – S.41-47.

Lutaj M.І., Slobods'kij V.A. Gavrilenko T.І., Kornіlіna O.M., Nemchina O.O. Koncentracіya endotelіnu-1 u plozmі krovі korelyuє z virazhenіstyu klіnіchnih proyavіv stabіl'noї stenokardії napruzhennya. Ukraїns'kij medichnij chasopis. 2004. №4(42):105-108.

Bel'china YU. B. Sostoyanie endoteliya u bol'nyh saharnym diabetom 1-go tipa i metabolicheskoj kardiomiopatiej / YU. B. Bel'china, L. K. Sokolova // Lіki Ukraїni. - 2013. - № 4. - S. 65-68. - Rezhim dostupu: http://nbuv.gov.ua/UJRN/likukr_2013_4_14.

Sirman, Ya.V; Savytskyi, I.V.; Gozhenko, A.I.; Badiuk, N.S.; Preys, N.I.; Dzygal, O.F. Von Willebrand factor level dynamic during the endothelial dysfunction development in experimental diabetic retinopathy / PharmacologyOnLine; Archives - 2020 - vol.3 - 247-260

Sirman Ya. V., Preys N. I., Savitsky I. V., Badiuk N. S., Blavatska O. M, Hrytsan I. I., Tsypoviaz S. V. Dynamics of vasoconstructor-vasodilation potential on the background of the development of experimental diabetic retinopathy / PharmacologyOnLine; Archives - 2021 - vol.1 – 90-95.

Downloads

  • PDF

Published

2021-10-29

How to Cite

1.
SIRMAN, Y., PREIS, N. & SAVYTSKYI , I. Research of changes in the level of endothelin-1 in experimental diabetic retinopathy. comparison of methods of correction. Journal of Education, Health and Sport [online]. 29 October 2021, T. 11, nr 10, s. 411–422. [accessed 29.3.2023]. DOI 10.12775/JEHS.2021.11.10.038.
  • PN-ISO 690 (Polish)
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 11 No. 10 (2021)

Section

Research Articles

License

Copyright (c) 2021 Y. Sirman, N. Preis, I. Savytskyi

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0

Stats

Number of views and downloads: 110
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

experimental diabetic retinopathy, endothelial dysfunction, endothelin-1, vasoconstriction, correction
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Karmelitański Instytut Duchowości w Krakowie
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop